<?xml version="1.0" encoding="us-ascii"?><InstanceReport xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema"><Version>2.2.0.25</Version><hasSegments>false</hasSegments><hasScenarios>false</hasScenarios><ReportLongName>10801 - Disclosure - Derivative Financial Instruments</ReportLongName><DisplayLabelColumn>true</DisplayLabelColumn><ShowElementNames>false</ShowElementNames><RoundingOption /><HasEmbeddedReports>false</HasEmbeddedReports><Columns><Column><Id>1</Id><IsAbstractGroupTitle>false</IsAbstractGroupTitle><LabelColumn>false</LabelColumn><CurrencyCode>USD</CurrencyCode><FootnoteIndexer /><hasSegments>false</hasSegments><hasScenarios>false</hasScenarios><MCU><KeyName>1/1/2011 - 3/31/2011
USD ($)

USD ($) / shares
</KeyName><CurrencySymbol>$</CurrencySymbol><contextRef><ContextID>Duration_1_1_2011_To_3_31_2011</ContextID><EntitySchema>http://www.sec.gov/CIK</EntitySchema><EntityValue>0001130385</EntityValue><PeriodDisplayName /><PeriodType>duration</PeriodType><PeriodStartDate>2011-01-01T00:00:00</PeriodStartDate><PeriodEndDate>2011-03-31T00:00:00</PeriodEndDate><Segments /><Scenarios /></contextRef><UPS><UnitProperty><UnitID>Unit12</UnitID><UnitType>Standard</UnitType><StandardMeasure><MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema><MeasureValue>USD</MeasureValue><MeasureNamespace>iso4217</MeasureNamespace></StandardMeasure><Scale>0</Scale></UnitProperty><UnitProperty><UnitID>Unit1</UnitID><UnitType>Standard</UnitType><StandardMeasure><MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema><MeasureValue>shares</MeasureValue><MeasureNamespace>xbrli</MeasureNamespace></StandardMeasure><Scale>0</Scale></UnitProperty><UnitProperty><UnitID>Unit13</UnitID><UnitType>Standard</UnitType><StandardMeasure><MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema><MeasureValue>pure</MeasureValue><MeasureNamespace>xbrli</MeasureNamespace></StandardMeasure><Scale>0</Scale></UnitProperty><UnitProperty><UnitID>Unit16</UnitID><UnitType>Divide</UnitType><NumeratorMeasure><MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema><MeasureValue>USD</MeasureValue><MeasureNamespace>iso4217</MeasureNamespace></NumeratorMeasure><DenominatorMeasure><MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema><MeasureValue>shares</MeasureValue><MeasureNamespace>xbrli</MeasureNamespace></DenominatorMeasure><Scale>0</Scale></UnitProperty></UPS><CurrencyCode>USD</CurrencyCode><OriginalCurrencyCode>USD</OriginalCurrencyCode></MCU><CurrencySymbol>$</CurrencySymbol><Labels><Label Id="1" Label="3 Months Ended" /><Label Id="2" Label="Mar. 31, 2011" /></Labels></Column></Columns><Rows><Row><Id>2</Id><IsAbstractGroupTitle>true</IsAbstractGroupTitle><Level>0</Level><ElementName>fwlt_DerivativesFinancialInstrumentsAbstract</ElementName><ElementPrefix>fwlt</ElementPrefix><IsBaseElement>false</IsBaseElement><BalanceType>na</BalanceType><PeriodType>duration</PeriodType><ShortDefinition>Derivatives Financial Instruments [Abstract]</ShortDefinition><IsReportTitle>false</IsReportTitle><IsSegmentTitle>false</IsSegmentTitle><IsSubReportEnd>false</IsSubReportEnd><IsCalendarTitle>false</IsCalendarTitle><IsTuple>false</IsTuple><IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow><IsEquityAdjustmentRow>false</IsEquityAdjustmentRow><IsBeginningBalance>false</IsBeginningBalance><IsEndingBalance>false</IsEndingBalance><IsReverseSign>false</IsReverseSign><PreferredLabelRole /><FootnoteIndexer /><Cells><Cell><Id>1</Id><IsNumeric>false</IsNumeric><IsRatio>false</IsRatio><DisplayZeroAsNone>false</DisplayZeroAsNone><NumericAmount>0</NumericAmount><RoundedNumericAmount>0</RoundedNumericAmount><NonNumbericText /><NonNumericTextHeader /><FootnoteIndexer /><CurrencyCode /><CurrencySymbol /><IsIndependantCurrency>false</IsIndependantCurrency><ShowCurrencySymbol>false</ShowCurrencySymbol><DisplayDateInUSFormat>false</DisplayDateInUSFormat><hasSegments>false</hasSegments><hasScenarios>false</hasScenarios></Cell></Cells><OriginalInstanceReportColumns /><Unit>Other</Unit><ElementDataType>xbrli:stringItemType</ElementDataType><SimpleDataType>string</SimpleDataType><ElementDefenition>Derivatives Financial Instruments [Abstract]</ElementDefenition><IsTotalLabel>false</IsTotalLabel><IsEPS>false</IsEPS><Label>Derivative Financial Instruments</Label></Row><Row><Id>3</Id><IsAbstractGroupTitle>false</IsAbstractGroupTitle><Level>0</Level><ElementName>us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</ElementName><ElementPrefix>us-gaap</ElementPrefix><IsBaseElement>true</IsBaseElement><BalanceType>na</BalanceType><PeriodType>duration</PeriodType><ShortDefinition>No definition available.</ShortDefinition><IsReportTitle>false</IsReportTitle><IsSegmentTitle>false</IsSegmentTitle><IsSubReportEnd>false</IsSubReportEnd><IsCalendarTitle>false</IsCalendarTitle><IsTuple>false</IsTuple><IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow><IsEquityAdjustmentRow>false</IsEquityAdjustmentRow><IsBeginningBalance>false</IsBeginningBalance><IsEndingBalance>false</IsEndingBalance><IsReverseSign>false</IsReverseSign><PreferredLabelRole>terselabel</PreferredLabelRole><FootnoteIndexer /><Cells><Cell><Id>1</Id><IsNumeric>false</IsNumeric><IsRatio>false</IsRatio><DisplayZeroAsNone>false</DisplayZeroAsNone><NumericAmount>0</NumericAmount><RoundedNumericAmount>0</RoundedNumericAmount><NonNumbericText>&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="font-family: 'Times New Roman',Times,serif;"&gt;

&lt;div style="margin-top: 12pt; font-size: 10pt;" align="left"&gt;&lt;b&gt;8. Derivative Financial Instruments&lt;/b&gt; &lt;/div&gt;

&lt;div style="margin-top: 6pt; font-size: 10pt;" align="left"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;We are exposed to certain risks relating to our ongoing business operations. The risks managed by using derivative financial instruments relate primarily to foreign currency exchange rate risk and, to a significantly lesser extent, interest rate risk. Derivative financial instruments are recognized as assets or liabilities at fair value in our consolidated balance sheet. &lt;/div&gt;

&lt;div align="center"&gt;

&lt;table style="font-size: 10pt;" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;&lt;td width="20%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="13%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="13%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 8pt;" valign="bottom"&gt;&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" colspan="22" nowrap="nowrap" align="center"&gt;&lt;b&gt;Fair Values of Derivative Financial Instruments&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 8pt;" valign="bottom"&gt;&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" colspan="6" nowrap="nowrap" align="center"&gt;&lt;b&gt;Asset Derivatives&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" colspan="6" nowrap="nowrap" align="center"&gt;&lt;b&gt;Liability Derivatives&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 8pt;" valign="bottom"&gt;&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;&lt;b&gt;Balance Sheet&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;&lt;b&gt;March 31,&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;&lt;b&gt;Balance Sheet&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;&lt;b&gt;March 31,&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 8pt;" valign="bottom"&gt;&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" colspan="2" nowrap="nowrap" align="center"&gt;&lt;b&gt;Location&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" colspan="2" nowrap="nowrap" align="center"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" colspan="2" nowrap="nowrap" align="center"&gt;&lt;b&gt;2010&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" colspan="2" nowrap="nowrap" align="center"&gt;&lt;b&gt;Location&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" colspan="2" nowrap="nowrap" align="center"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" colspan="2" nowrap="nowrap" align="center"&gt;&lt;b&gt;2010&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background: #cceeff;" valign="bottom"&gt;&lt;td&gt;

&lt;div style="text-indent: -15px; margin-left: 15px;"&gt;&lt;b&gt;Derivatives designated as hedging instruments&lt;/b&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td&gt;

&lt;div style="text-indent: -15px; margin-left: 30px;"&gt;Interest rate swap contracts&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td colspan="3" align="left"&gt;Other assets&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td colspan="3" align="left"&gt;Other long-term liabilities&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;5,860&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;6,903&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background: #cceeff;" valign="bottom"&gt;&lt;td&gt;

&lt;div style="text-indent: -15px; margin-left: 15px;"&gt;&lt;b&gt;Derivatives not designated as hedging instruments&lt;/b&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td valign="top"&gt;

&lt;div style="text-indent: -15px; margin-left: 45px;"&gt;Foreign currency forward contracts&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td colspan="2" align="left"&gt;

&lt;div style="text-indent: -15px; margin-left: 15px;"&gt;Contracts in process or billings in excess of costs and estimated earnings on uncompleted contracts&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;3,299&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;2,112&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td valign="top" colspan="2" align="left"&gt;

&lt;div style="text-indent: -15px; margin-left: 15px;"&gt;Contracts in process or billings in excess of costs and estimated earnings on uncompleted contracts&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;1,263&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;2,978&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background: #cceeff;" valign="bottom"&gt;&lt;td&gt;

&lt;div style="text-indent: -15px; margin-left: 30px;"&gt;Foreign currency forward contracts&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td colspan="3" align="left"&gt;Other accounts receivable&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;298&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;367&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td colspan="3" align="left"&gt;Accounts payable&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;38&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;&lt;td&gt;

&lt;div style="text-indent: -15px; margin-left: 15px;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-top: #000000 1px solid;" colspan="2" nowrap="nowrap" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-top: #000000 1px solid;" colspan="2" nowrap="nowrap" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-top: #000000 1px solid;" colspan="2" nowrap="nowrap" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-top: #000000 1px solid;" colspan="2" nowrap="nowrap" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td&gt;

&lt;div style="text-indent: -15px; margin-left: 15px;"&gt;&lt;b&gt;Total derivatives&lt;/b&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
&lt;td align="right"&gt;&lt;b&gt;3,597&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
&lt;td align="right"&gt;&lt;b&gt;2,479&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
&lt;td align="right"&gt;&lt;b&gt;7,123&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
&lt;td align="right"&gt;&lt;b&gt;9,919&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;&lt;td&gt;

&lt;div style="text-indent: -15px; margin-left: 15px;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-top: #000000 3px double;" colspan="2" nowrap="nowrap" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-top: #000000 3px double;" colspan="2" nowrap="nowrap" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-top: #000000 3px double;" colspan="2" nowrap="nowrap" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-top: #000000 3px double;" colspan="2" nowrap="nowrap" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;

&lt;div style="margin-top: 6pt; font-size: 10pt;" align="left"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;u&gt;&lt;i&gt;Foreign Currency Exchange Rate Risk&lt;/i&gt;&lt;/u&gt; &lt;/div&gt;

&lt;div style="margin-top: 6pt; font-size: 10pt;" align="left"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;We operate on a worldwide basis with substantial operations in Europe that subject us to translation risk mainly relative to the Euro and British pound. Under our risk management policies, we do not hedge translation risk exposure. All activities of our affiliates are recorded in their functional currency, which is typically the local currency in the country of domicile of the affiliate. In the ordinary course of business, our affiliates enter into transactions in currencies other than their respective functional currencies. We seek to minimize the resulting foreign currency transaction risk by contracting for the procurement of goods and services in the same currency as the sales value of the related long-term contract. We further mitigate the risk through the use of foreign currency forward contracts. &lt;/div&gt;

&lt;div style="margin-top: 6pt; font-size: 10pt;" align="left"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;The notional amount of foreign currency forward contracts provides one measure of the transaction volume outstanding as of the balance sheet date. As of March&amp;nbsp;31, 2011, we had a total gross notional amount of $232,043 related to foreign currency forward contracts. Amounts ultimately realized upon final settlement of these financial instruments, along with the gains and losses on the underlying exposures within our long-term contracts, will depend on actual market exchange rates during the remaining life of the instruments. The contracts mature between fiscal years 2011 and 2013. &lt;/div&gt;

&lt;div style="margin-top: 6pt; font-size: 10pt;" align="left"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;We are exposed to credit loss in the event of non-performance by the counterparties. These counterparties are commercial banks that are primarily rated "BBB+" or better by S&amp;amp;P (or the equivalent by other recognized credit rating agencies). &lt;/div&gt;

&lt;div style="margin-top: 6pt; font-size: 10pt;" align="left"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;Increases in the fair value of the currencies sold forward result in losses while increases in the fair value of the currencies bought forward result in gains. For foreign currency forward contracts used to mitigate currency risk on our projects, the gain or loss from the portion of the mark-to-market adjustment related to the completed portion of the underlying project is included in cost of operating revenues at the same time as the underlying foreign currency exposure occurs. The gain or loss from the remaining portion of the mark-to-market adjustment, specifically the portion relating to the uncompleted portion of the underlying project is reflected directly in cost of operating revenues in the period in which the mark-to-market adjustment occurs. We also utilize foreign currency forward contracts to mitigate non-project related currency risks, which are recorded in other deductions, net. The gain or loss from the remaining uncompleted portion of our projects and other non-project related transactions were as follows: &lt;/div&gt;18 &lt;/div&gt;

&lt;h5 align="left"&gt;&lt;a href="blank#Y90624tocpage"&gt;Table of Contents&lt;/a&gt;&lt;/h5&gt;

&lt;div style="font-family: 'Times New Roman',Times,serif;"&gt;

&lt;div align="center"&gt;

&lt;table style="font-size: 10pt;" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;&lt;td width="35%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="33%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 8pt;" valign="bottom"&gt;&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td colspan="6" nowrap="nowrap" align="center"&gt;&lt;b&gt;Amount of Gain/(Loss) Recognized in&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 8pt;" valign="bottom"&gt;&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" colspan="6" nowrap="nowrap" align="center"&gt;&lt;b&gt;Income on Derivatives&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 8pt;" valign="bottom"&gt;&lt;td nowrap="nowrap" align="left"&gt;&lt;b&gt;Derivatives Not Designated as&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;&lt;b&gt;Location of Gain/(Loss) Recognized&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" colspan="6" nowrap="nowrap" align="center"&gt;&lt;b&gt;Fiscal Three Months Ended March 31,&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 8pt;" valign="bottom"&gt;&lt;td style="border-bottom: #000000 1px solid;" nowrap="nowrap" align="left"&gt;&lt;b&gt;Hedging Instruments&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" colspan="2" nowrap="nowrap" align="center"&gt;&lt;b&gt;in Income on Derivative&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" colspan="2" nowrap="nowrap" align="center"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" colspan="2" nowrap="nowrap" align="center"&gt;&lt;b&gt;2010&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background: #cceeff;" valign="bottom"&gt;&lt;td&gt;

&lt;div style="text-indent: -15px; margin-left: 15px;"&gt;Foreign currency forward contracts&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td colspan="3" align="left"&gt;Cost of operating revenues&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;1,814&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;(1,451&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td&gt;

&lt;div style="text-indent: -15px; margin-left: 15px;"&gt;Foreign currency forward contracts&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="left"&gt;Other deductions, net&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;70&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;(188&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;&lt;td&gt;

&lt;div style="text-indent: -15px; margin-left: 15px;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-top: #000000 0px solid;" colspan="2" nowrap="nowrap" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-top: #000000 1px solid;" colspan="2" nowrap="nowrap" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-top: #000000 1px solid;" colspan="2" nowrap="nowrap" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background: #cceeff;" valign="bottom"&gt;&lt;td&gt;

&lt;div style="text-indent: -15px; margin-left: 15px;"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
&lt;td align="right"&gt;&lt;b&gt;1,884&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
&lt;td align="right"&gt;&lt;b&gt;(1,639&lt;/b&gt;&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;&lt;b&gt;)&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;&lt;td&gt;

&lt;div style="text-indent: -15px; margin-left: 15px;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-top: #000000 3px double;" colspan="2" nowrap="nowrap" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-top: #000000 3px double;" colspan="2" nowrap="nowrap" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;

&lt;div style="margin-top: 6pt; font-size: 10pt;" align="left"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;The mark-to-market adjustments on foreign currency forward exchange contracts for these unrealized gains or losses are primarily recorded in either contracts in process or billings in excess of costs and estimated earnings on uncompleted contracts on the consolidated balance sheet. &lt;/div&gt;

&lt;div style="margin-top: 6pt; font-size: 10pt;" align="left"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;During the fiscal first three months ended March&amp;nbsp;31, 2011 and 2010, we included net cash inflows/(outflows) on the settlement of derivatives of $182 and $(2,548), respectively, within the "net change in contracts in process and billings in excess of costs and estimated earnings on uncompleted contracts," a component of cash flows from operating activities in the consolidated statement of cash flows. &lt;/div&gt;

&lt;div style="margin-top: 6pt; font-size: 10pt;" align="left"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;u&gt;&lt;i&gt;Interest Rate Risk&lt;/i&gt;&lt;/u&gt; &lt;/div&gt;

&lt;div style="margin-top: 6pt; font-size: 10pt;" align="left"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;We use interest rate swap contracts to manage interest rate risk associated with some of our variable rate special-purpose limited recourse project debt. The aggregate notional amount of the receive-variable/pay-fixed interest rate swaps was $78,100 as of March&amp;nbsp;31, 2011. &lt;/div&gt;

&lt;div style="margin-top: 6pt; font-size: 10pt;" align="left"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;Upon entering into the swap contracts, we designate the interest rate swaps as cash flow hedges. We assess at inception, and on an ongoing basis, whether the interest rate swaps are highly effective in offsetting changes in the cash flows of the project debt. Consequently, we record the fair value of interest rate swap contracts in our consolidated balance sheet at each balance sheet date. Changes in the fair value of the interest rate swap contracts are recorded as a component of other comprehensive income. &lt;/div&gt;

&lt;div style="margin-top: 6pt; font-size: 10pt;" align="left"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;The impact from interest rate swap contracts in cash flow hedging relationships was as follows: &lt;/div&gt;

&lt;div align="center"&gt;

&lt;table style="font-size: 10pt;" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;&lt;td width="76%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 8pt;" valign="bottom"&gt;&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" colspan="6" nowrap="nowrap" align="center"&gt;&lt;b&gt;Fiscal Three Months Ended March 31,&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 8pt;" valign="bottom"&gt;&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" colspan="2" nowrap="nowrap" align="center"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" colspan="2" nowrap="nowrap" align="center"&gt;&lt;b&gt;2010&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td&gt;

&lt;div style="text-indent: -15px; margin-left: 15px;"&gt;Gain/(loss) recognized in Other comprehensive income&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;847&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;(2,936&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td&gt;

&lt;div style="text-indent: -15px; margin-left: 15px;"&gt;Loss reclassified from Accumulated other comprehensive loss&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;615&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;1,122&lt;/td&gt;
&lt;td&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/div&gt;</NonNumbericText><NonNumericTextHeader>8. Derivative Financial Instruments

&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;We are exposed to certain risks relating to our ongoing business operations. The risks</NonNumericTextHeader><FootnoteIndexer /><CurrencyCode /><CurrencySymbol /><IsIndependantCurrency>false</IsIndependantCurrency><ShowCurrencySymbol>false</ShowCurrencySymbol><DisplayDateInUSFormat>false</DisplayDateInUSFormat><hasSegments>false</hasSegments><hasScenarios>false</hasScenarios></Cell></Cells><OriginalInstanceReportColumns /><Unit>Other</Unit><ElementDataType>us-types:textBlockItemType</ElementDataType><SimpleDataType>string</SimpleDataType><ElementDefenition>This element can be used to disclose the entity's entire derivative instruments and hedging activities disclosure as a single block of text. Describes an entity's risk management strategies, derivatives in hedging activities and non-hedging derivative instruments, the assets, obligations, liabilities, revenues and expenses arising there from, and the amounts of and methodologies and assumptions used in determining the amounts of such items.</ElementDefenition><ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 133
 -Paragraph 45

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 133
 -Paragraph 44

</ElementReferences><IsTotalLabel>false</IsTotalLabel><IsEPS>false</IsEPS><Label>Derivative Financial Instruments</Label></Row></Rows><Footnotes /><NumberOfCols>1</NumberOfCols><NumberOfRows>2</NumberOfRows><ReportName>Derivative Financial Instruments</ReportName><MonetaryRoundingLevel>UnKnown</MonetaryRoundingLevel><SharesRoundingLevel>UnKnown</SharesRoundingLevel><PerShareRoundingLevel>UnKnown</PerShareRoundingLevel><ExchangeRateRoundingLevel>UnKnown</ExchangeRateRoundingLevel><HasCustomUnits>false</HasCustomUnits><SharesShouldBeRounded>true</SharesShouldBeRounded></InstanceReport>
